Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT02997475Completed

Neural Bases of Multiple Forms of Self-regulatory Control in Bulimia Nervosa

Role: collaborator

NCT02963220Not ApplicableCompleted

Cognitive-Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder: A Treatment Development and Pilot Study

Role: collaborator

NCT02883413Not ApplicableCompleted

Cognitive Remediation Therapy for Adolescents With Anorexia Nervosa

Role: collaborator

NCT02419326Not ApplicableCompleted

Uniting Couples In the Treatment of Eating Disorders (UNITE)

Role: collaborator

NCT01174602Not ApplicableCompleted

Inpatient Exposure Therapy and Response Prevention & Cognitive Remediation Therapy for Anorexia Nervosa

Role: collaborator

NCT00755820Completed

Food Exposure Therapy in Anorexia Nervosa

Role: collaborator

All 6 trials loaded